000 01471 a2200361 4500
005 20250517122009.0
264 0 _c20170222
008 201702s 0 0 eng d
022 _a1619-7089
024 7 _a10.1007/s00259-016-3534-y
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKluge, Regine
245 0 0 _aDo paraneoplastic changes in diffuse FDG organ uptake predict relapse? - Wait for confirmation study : Reply to Jorgov et al. Eur J Nucl Med Mol Imaging. 2016 Jul;43(7):1220--30.
_h[electronic resource]
260 _bEuropean journal of nuclear medicine and molecular imaging
_cJan 2017
300 _a170-171 p.
_bdigital
500 _aPublication Type: Letter
650 0 4 _aAdolescent
650 0 4 _aChild
650 0 4 _aFluorodeoxyglucose F18
_xpharmacokinetics
650 0 4 _aHodgkin Disease
_xdiagnostic imaging
650 0 4 _aHumans
650 0 4 _aNeoplasm Recurrence, Local
_xdiagnostic imaging
650 0 4 _aParaneoplastic Syndromes
_xdiagnostic imaging
650 0 4 _aPositron Emission Tomography Computed Tomography
_xmethods
650 0 4 _aPositron-Emission Tomography
_xmethods
650 0 4 _aPrognosis
650 0 4 _aRisk Assessment
_xmethods
700 1 _aKurch, Lars
700 1 _aGeorgi, Thomas
700 1 _aHasenclever, Dirk
773 0 _tEuropean journal of nuclear medicine and molecular imaging
_gvol. 44
_gno. 1
_gp. 170-171
856 4 0 _uhttps://doi.org/10.1007/s00259-016-3534-y
_zAvailable from publisher's website
999 _c26533256
_d26533256